136 related articles for article (PubMed ID: 2344964)
1. Establishment and characterization of UM-EC-2, a tamoxifen-sensitive, estrogen receptor-negative human endometrial carcinoma cell line.
Grenman SE; Worsham MJ; Van Dyke DL; England B; McClatchey KD; Babu VR; Roberts JA; Mäenpää J; Carey TE
Gynecol Oncol; 1990 May; 37(2):188-99. PubMed ID: 2344964
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B.
Grénman SE; Van Dyke DL; Worsham MJ; England B; McClatchey KD; Hopkins M; Babu VR; Grénman R; Carey TE
Int J Cancer; 1990 May; 45(5):920-7. PubMed ID: 2335395
[TBL] [Abstract][Full Text] [Related]
3. UM-EC-1, a new hypodiploid human cell line derived from a poorly differentiated endometrial cancer.
Grenman SE; Van Dyke DL; Worsham MJ; del Rosario F; Roberts JA; McClatchey KD; Schwartz DR; Babu VR; Carey TE
Cancer Res; 1988 Apr; 48(7):1864-73. PubMed ID: 3349465
[TBL] [Abstract][Full Text] [Related]
4. In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate.
Grenman SE; Roberts JA; England BG; Grönroos M; Carey TE
Gynecol Oncol; 1988 Jun; 30(2):239-50. PubMed ID: 2967231
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice.
Satyaswaroop PG; Zaino RJ; Mortel R
Cancer Res; 1984 Sep; 44(9):4006-10. PubMed ID: 6744316
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of an estrogen receptor positive 3'-methyl-4-dimethylaminoazobenzene induced hepatoma cell line of rat and investigation of hormonal therapy].
Kameda H
Hokkaido Igaku Zasshi; 1996 Nov; 71(6):711-26. PubMed ID: 8996840
[TBL] [Abstract][Full Text] [Related]
7. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice.
Friedl A; Gottardis MM; Pink J; Buchler DA; Jordan VC
Cancer Res; 1989 Sep; 49(17):4758-64. PubMed ID: 2758409
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
9. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
[TBL] [Abstract][Full Text] [Related]
10. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
11. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
Gottardis MM; Robinson SP; Satyaswaroop PG; Jordan VC
Cancer Res; 1988 Feb; 48(4):812-5. PubMed ID: 3338079
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects of tamoxifen on UM-SCC head and neck cancer cell lines: correlation with the estrogen and progesterone receptor content.
Grenman R; Virolainen E; Shapira A; Carey T
Int J Cancer; 1987 Jan; 39(1):77-81. PubMed ID: 3793272
[TBL] [Abstract][Full Text] [Related]
13. Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endometrial carcinoma (EnCa101) in athymic mice.
Gottardis MM; Ricchio ME; Satyaswaroop PG; Jordan VC
Cancer Res; 1990 Jun; 50(11):3189-92. PubMed ID: 2334915
[TBL] [Abstract][Full Text] [Related]
14. Comparative study on the induction of cytostasis and apoptosis by ICI 182,780 and tamoxifen in an estrogen receptor-negative ovarian cancer cell line.
Ercoli A; Scambia G; Fattorossi A; Raspaglio G; Battaglia A; Cicchillitti L; Malorni W; Rainaldi G; Benedetti Panici P; Mancuso S
Int J Cancer; 1998 Mar; 76(1):47-54. PubMed ID: 9533761
[TBL] [Abstract][Full Text] [Related]
15. Characterization of tamoxifen stimulated MCF-7 tumor variants grown in athymic mice.
Wolf DM; Jordan VC
Breast Cancer Res Treat; 1994; 31(1):117-27. PubMed ID: 7981452
[TBL] [Abstract][Full Text] [Related]
16. In vitro cytotoxicity of 4'-OH-tamoxifen and estradiol in human endometrial adenocarcinoma cells HEC-1A and HEC-1B.
Cuevas ME; Lindeman TE
Oncol Rep; 2015 Jan; 33(1):464-70. PubMed ID: 25351552
[TBL] [Abstract][Full Text] [Related]
17. Interrelationship between estradiol and tamoxifen responses for clinical breast carcinoma cells cultured on contact-sensitive plates.
Matsuoka H; Nakamura Y; Ueo H; Sugimachi K; Tomoda H; Saito T; Seo Y
Jpn J Cancer Res; 1994 Jun; 85(6):619-25. PubMed ID: 8063615
[TBL] [Abstract][Full Text] [Related]
18. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
19. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
20. Effects of the new selective estrogen receptor modulator LY353381.HCl (Arzoxifene) on human endometrial cancer growth in athymic mice.
Dardes RC; Bentrem D; O'Regan RM; Schafer JM; Jordan VC
Clin Cancer Res; 2001 Dec; 7(12):4149-55. PubMed ID: 11751515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
